Quantifying absolute benefit for adjuvant treatment options in renal cell carcinoma: A living interactive systematic review and network meta-analysis.

Objective: To assess comparative effectiveness of adjuvant therapies for renal cell carcinoma and quantify the absolute benefit of adjuvant treatments by clinicopathological risk groups.

Methods: This 'living' review was conducted using Living Interactive Evidence (LIvE) synthesis framework.

Results: The 'living' results are available on an interactive website.